New oral lesion by regorafenib: A case report

Oral Dis. 2023 Jan;29(1):337-338. doi: 10.1111/odi.14208. Epub 2022 Apr 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Humans
  • Phenylurea Compounds* / therapeutic use
  • Pyridines / adverse effects

Substances

  • regorafenib
  • Phenylurea Compounds
  • Pyridines
  • Antineoplastic Agents